Skip to content
Annalist
Companies Compare Method Data Quality For AI agents

AstraZeneca PLC

AZN · LSE · Health care, pharmaceuticals · United Kingdom · IFRS · Fiscal year ends December

Latest report: FY2025, the fiscal year ended 31 December 2025. Snapshot FY2025_73abca9a.

Overview

Revenue, fiscal year
+8.6% year on year
Operating profit, fiscal year
+37.4% year on year
Net income, fiscal year
+45.3% year on year
Diluted EPS, fiscal year
+45.3% year on year
Operating margin, fiscal year
+4.9pp year on year
Return on equity, fiscal year
+5.3pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest fiscal year, with their history over earlier years.

  1. Revenue for the fiscal year ended 31 December 2025 was US$58.7 billion, 8.6% higher than in the previous fiscal year.

    Weakenedin FY2025 · stated since FY2023
    Rule: Revenue against the previous fiscal year · Sources Annual financial report 2025-12
    History of this finding, 3 records
    1. FY2025 WeakenedRevenue for the fiscal year ended 31 December 2025 was US$58.7 billion, 8.6% higher than in the previous fiscal year.Recorded from FY2025_73abca9a · data update
    2. FY2024 StrengthenedRevenue for the fiscal year ended 31 December 2024 was US$54.1 billion, 18.0% higher than in the previous fiscal year.Reconstructed · data update
    3. FY2023 NewRevenue for the fiscal year ended 31 December 2023 was US$45.8 billion, 3.3% higher than in the previous fiscal year.Reconstructed · initial
  2. Net income attributable to the company for fiscal 2025 was US$10.2 billion, 45.3% higher than in the previous fiscal year.

    Strengthenedin FY2025 · stated since FY2023
    Rule: Net income against the previous fiscal year · Sources Annual financial report 2025-12
    History of this finding, 3 records
    1. FY2025 StrengthenedNet income attributable to the company for fiscal 2025 was US$10.2 billion, 45.3% higher than in the previous fiscal year.Recorded from FY2025_73abca9a · data update
    2. FY2024 WeakenedNet income attributable to the company for fiscal 2024 was US$7.0 billion, 18.1% higher than in the previous fiscal year.Reconstructed · data update
    3. FY2023 NewNet income attributable to the company for fiscal 2023 was US$6.0 billion, 81.1% higher than in the previous fiscal year.Reconstructed · initial
  3. The operating margin for fiscal 2025 was 23.4%, 4.9 percentage points higher than a year earlier.

    Strengthenedin FY2025 · stated since FY2023
    Rule: Operating margin against a year earlier · Sources Annual financial report 2025-12
    History of this finding, 3 records
    1. FY2025 StrengthenedThe operating margin for fiscal 2025 was 23.4%, 4.9 percentage points higher than a year earlier.Recorded from FY2025_73abca9a · data update
    2. FY2024 WeakenedThe operating margin for fiscal 2024 was 18.5%, 0.6 percentage points higher than a year earlier.Reconstructed · data update
    3. FY2023 NewThe operating margin for fiscal 2023 was 17.9%, 9.4 percentage points higher than a year earlier.Reconstructed · initial
  4. Return on equity for fiscal 2025 was 22.9%, against 17.6% a year earlier.

    Strengthenedin FY2025 · stated since FY2023
    Rule: Return on equity against a year earlier · Sources Annual financial report 2025-12, Annual financial report 2024-12
    History of this finding, 3 records
    1. FY2025 StrengthenedReturn on equity for fiscal 2025 was 22.9%, against 17.6% a year earlier.Recorded from FY2025_73abca9a · data update
    2. FY2024 WeakenedReturn on equity for fiscal 2024 was 17.6%, against 15.6% a year earlier.Reconstructed · data update
    3. FY2023 NewReturn on equity for fiscal 2023 was 15.6%, against 8.6% a year earlier.Reconstructed · initial
  5. Free cash flow for fiscal 2025 was US$11.8 billion, and operating cash flow was 1.4 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Strengthenedin FY2025 · stated since FY2023
    Rule: Free cash flow · Sources Annual financial report 2025-12
    History of this finding, 3 records
    1. FY2025 StrengthenedFree cash flow for fiscal 2025 was US$11.8 billion, and operating cash flow was 1.4 times net income attributable to the company.Recorded from FY2025_73abca9a · data update
    2. FY2024 StrengthenedFree cash flow for fiscal 2024 was US$9.9 billion, and operating cash flow was 1.7 times net income attributable to the company.Reconstructed · data update
    3. FY2023 NewFree cash flow for fiscal 2023 was US$9.0 billion, and operating cash flow was 1.7 times net income attributable to the company.Reconstructed · initial
  6. Net debt was US$23.9 billion at 31 December 2025.

    Confirmedin FY2025 · stated since FY2023
    Rule: Net debt or net cash · Sources Annual financial report 2025-12
    History of this finding, 3 records
    1. FY2025 ConfirmedNet debt was US$23.9 billion at 31 December 2025.Recorded from FY2025_73abca9a · data update
    2. FY2024 StrengthenedNet debt was US$24.8 billion at 31 December 2024.Reconstructed · data update
    3. FY2023 NewNet debt was US$22.8 billion at 31 December 2023.Reconstructed · initial

Records before FY2025 are reconstructed from the latest snapshot. Ledger: findings.json.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents5 documents, latest Annual financial report for the year to 31 December 2025List
DownloadsExcel workbook · JSON
SnapshotFY2025_73abca9a

Corporate Events

Corporate events are listed for companies whose figures come from 10-K and 10-Q filings; none are listed for this company.

Earnings, Returns and Balance Sheet

Revenue

By fiscal year, US dollars

Operating Profit

By fiscal year, US dollars

Profit Attributable to Owners of the Parent

By fiscal year, US dollars

Margins

By fiscal year, per cent

Returns

By fiscal year, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by fiscal year, US dollars

Net Debt

Total debt less cash and short-term investments, at fiscal year end, US dollars

Diluted Earnings per Share

By fiscal year, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a figure derived from other figures of the same report.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first. A report that states no date of publication carries the date on which the public index of structured annual reports added it.

DocumentDateId
Annual financial report for the year to 31 December 20254 Mar 2026, added to the indexAFR:PY6ZZQWO2IZFZC3IOL08-2025-12-31-0
Annual financial report for the year to 31 December 202425 Feb 2025, added to the indexAFR:PY6ZZQWO2IZFZC3IOL08-2024-12-31-0
Annual financial report for the year to 31 December 202320 Feb 2024, added to the indexAFR:PY6ZZQWO2IZFZC3IOL08-2023-12-31-0
Annual financial report for the year to 31 December 202222 Feb 2023, added to the indexAFR:PY6ZZQWO2IZFZC3IOL08-2022-12-31-0
Annual financial report for the year to 31 December 20218 Mar 2022, added to the indexAFR:PY6ZZQWO2IZFZC3IOL08-2021-12-31-0

Checks

320320 checks, all passed
Fiscal calendar11 passedFiscal years last 350 to 380 days, and each starts on the day after the one before. Checked at error level.
Coverage2 passedThe latest fiscal year gives total assets and a profit figure. Checked at error level.
Balance sheet identity6 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Gross profit6 passedRevenue less cost of sales equals the gross profit that the company presents. A gross profit that differs is withheld, and so is a cost of sales that the company gives without gross profit. Checked at warning level.
Earnings per share6 passedProfit divided by earnings per share gives a number of shares in line with the other years. Checked at warning level.
Agreement with the 20-F289 passedEach figure equals the figure of the annual report on Form 20-F that the company files with the SEC for the same fiscal year. A figure that differs is withheld. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published292
Proven by a check99.0%, 289 values
Confirmed by a second document99.0%, 289 values
Derived from reported figures0.0%, 0 values
Values withheld0
Restated figures tracked3
Changes compared on one basis0
Company lines mapped0 of 0 reviewed

Citation

Annalist, AstraZeneca PLC, snapshot astrazeneca/FY2025_73abca9a (as of FY2025); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2025_73abca9a · dataset SHA-256 73abca9aef6613bc110cf78a4c4d6cf62dc2ea7fc4ddbe64a5690e3af801b181 · findings rules 0.4

Data: info.json · dataset.json · validation.json · documents.json